Personal information

No personal information available

Activities

Employment (1)

Necmettin Erbakan University Meram Faculty of Medicine: Konya, TR

2018-10-05 to present | Associate Professor (Medical Oncology)
Employment
Source: Self-asserted source
murat araz

Education and qualifications (3)

Selçuk University Faculty of Medicine: Konya, TR

2010-09 to 2014-05 | Fellow (Medical Oncology)
Education
Source: Self-asserted source
murat araz

Goztepe Education and Training Hospital: İstanbul, TR

2003 to 2008 | Research Assistant (Internal Medicine)
Education
Source: Self-asserted source
murat araz

İstanbul University Cerrahpasa Faculty of Medicine: İstanbul, TR

1996-09 to 2002-08 | Student
Education
Source: Self-asserted source
murat araz

Works (33)

Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer

Journal of Oncology Pharmacy Practice
2025-02 | Journal article
Contributors: Oğuzhan Yıldız; Ali Fuat Gürbüz; Melek Karakurt Eryılmaz; Murat Araz; Talat Aykut; Özlem Şahin; Naciye Hilal Büyükboyacı; Zeliha Çelik; Mehmet Artaç
Source: check_circle
Crossref

Lorlatinib experience in a patient with ALK + non-small cell lung cancer on hemodialysis: A case report

Journal of Oncology Pharmacy Practice
2025-02 | Journal article
Contributors: Ali Fuat Gürbüz; Melek Karakurt Eryılmaz; Oğuzhan Yıldız; Bahattin Engin Kaya; Murat Araz; Mehmet Artaç
Source: check_circle
Crossref

Prognostic Nutritional Index as a Biomarker in Metastatic Hormone‐Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization

The Prostate
2025-02-19 | Journal article
Contributors: Muhammet Bekir Hacioglu; Ahmet Kucukarda; Ivo Gokmen; Ali Fuat Gurbuz; Murat Araz; Fatma Akdag Kahvecioglu; Ilhan Hacibekiroglu; Orhun Akdoğan; Ozan Yazıcı; Fatma Aysun Akkus et al.
Source: check_circle
Crossref

Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks?

European Journal of Clinical Pharmacology
2025-02-19 | Journal article
Contributors: İsmail Beypınar; Semiha Urvay; Müslih Ürün; Berrak Erçek; Hacer Demir; Canan Yıldız; Murat Araz; Ahmet Oruç; Utku Özilice; Onur Yazdan Balçık
Source: check_circle
Crossref

The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis

Medicina
2025-01 | Journal article | Author
Contributors: Nadiye; sedat yıldırım; Ali Fuat Gurbuz; Delyadil Karakaş Kılıç; Esra Zeynelgil; YE Altintas; BERİVAN DENİZ ÇİMİK; Yeşim Ağyol; Ali Kaan; Pınar Erel et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

A preliminary study on the prognostic significance of cysteine-rich EGF ligand domain 2 protein (CRELD2) in patients with triple negative breast cancer

Biomolecules and Biomedicine
2025-01-24 | Journal article
Contributors: Mehmet Zahid Kocak; Murat Araz; Siddika Findik; Aykut Demirkiran; Mustafa Korkmaz; Melek Karakurt Eryilmaz; Mehmet Artac
Source: check_circle
Crossref

Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy

Journal of Oncology Pharmacy Practice
2024-08-28 | Journal article
Contributors: Murat Araz; Ismail Beypinar; Fatih Inci; Lokman Koral; Mehmet Zahid Kocak; Mustafa Korkmaz; Aykut Demirkiran; Melek Karakurt Eryilmaz; Mehmet Artac
Source: check_circle
Crossref

Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study

Current Medical Research and Opinion
2024-07-02 | Journal article
Contributors: Kadriye Bir Yücel; Muzaffer Uğraklı; Serhat Sekmek; Nilgün Yıldırım; Fatih Gürler; Ozan Yazıcı; Ahmet Özet; Öznur Bal; Murat Araz; Mehmet Artaç et al.
Source: check_circle
Crossref

The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line

European Journal of Clinical Pharmacology
2024-06 | Journal article
Contributors: Mustafa Korkmaz; Melek Karakurt Eryılmaz; Mehmet Zahid Koçak; Muhammed Muhiddin Er; Engin Hendem; Aykut Demirkıran; Murat Araz; Mehmet Artaç
Source: check_circle
Crossref

Is the Prognostic Nutritional Index a Prognostic Marker for the Survival of Patients with Lymph-Node Positive Stage II-III Gastric Cancer Who Receive Adjuvant Chemotherapy?

Journal of Gastrointestinal Cancer
2023-09 | Journal article
Contributors: Mustafa Korkmaz; Melek Karakurt Eryılmaz; Muhammed Muhiddin Er; Mehmet Zahid Koçak; Aykut Demirkıran; Mustafa Karaağaç; Murat Araz; Mehmet Artaç; Zahid Mehmet Koçak
Source: check_circle
Crossref

Prognostic Significance of Adipose Tissue Distribution and Metabolic Activity in PET/CT in Patients with Metastatic Colorectal Cancer

Journal of Gastrointestinal Cancer
2023-06 | Journal article
Contributors: Tuba Karaçelik; Buğra Kaya; Mustafa Korkmaz; Mustafa Karaağaç; Murat Araz; Melek Karakurt Eryılmaz; Hakan Şat Bozcuk; Mehmet Artaç
Source: check_circle
Crossref

A new prognostic factor in patients with recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan: Hemoglobin, albumin, lymphocytes and platelets (HALP) score

Archives of Current Medical Research
2023-01-31 | Journal article
Contributors: Mustafa KORKMAZ; Melek KARAKURT ERYILMAZ; Mehmet Zahid KOÇAK; Aykut DEMİRKIRAN; Murat ARAZ; Mustafa KARAAĞAÇ; Mehmet ARTAÇ
Source: check_circle
Crossref

Timik Tümörlerin Sistemik Tedavisinde Gelişmeler

Mevlana Medical Sciences
2022-12-14 | Journal article
Contributors: Murat Araz
Source: check_circle
Crossref

Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer

Journal of Oncology Pharmacy Practice
2022-04 | Journal article
Contributors: Muzaffer Uğraklı; Murat Araz; Aykut Demirkıran; Ahmet Faruk Çelik; Melek Karakurt Eryılmaz; Mustafa Karaağaç; Mehmet Artaç
Source: check_circle
Crossref

The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer

Journal of Gastrointestinal Cancer
2022-03 | Journal article
Contributors: Ismail Beypinar; Hacer Demir; Murat Araz; Meltem Baykara; Nuri Faruk Aykan
Source: check_circle
Crossref

Immunotherapy era in the treatment of small cell lung cancer

Medical Oncology
2021-07 | Journal article
Contributors: Murat Araz; Melek Karakurt Eryilmaz
Source: check_circle
Crossref

Irinotecan-induced NASH and liver failure

Clinics and Research in Hepatology and Gastroenterology
2021-05 | Journal article
Contributors: Murat Araz; Fahriye Kilinc; Ulku Kerimoglu; Muharrem Keskin; Tevfik Kucukkartallar
Source: check_circle
Crossref

The Prognostic Value of Serum Semaphorin3A and VEGF Levels in Patients with Metastatic Colorectal Cancer

Journal of Gastrointestinal Cancer
2020-06-20 | Journal article
Contributors: Tuba Karpuz; Murat Araz; Levent Korkmaz; Ibrahim Kılınc; Sidika Findik; Mustafa Karaagaç; Melek Karakurt Eryilmaz; Mehmet Artac
Source: check_circle
Crossref

Bir Üniversite Hastanesi İç Hastalıkları Kliniği Tarafından Bakılan Konsültasyonların Değerlendirilmesi

Online Türk Sağlık Bilimleri Dergisi
2020-03-31 | Journal article
Contributors: Alper Emre KURT; Murat ARAZ; Sinan KAZAN
Source: check_circle
Crossref

ANTİBİYOTİK İLİŞKİLİ DRESS SENDROMU:NADİR BİR OLGU

Kocatepe Tıp Dergisi
2020-01-16 | Journal article
Contributors: Alper Emre Kurt; Tevfik Solakoğlu; Murat Araz
Source: check_circle
Crossref

Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience

2019 | Journal article
Part of ISSN: 2147-0634
Source: Self-asserted source
murat araz

The compliance with antiemetic guidelines of Turkish medical oncologists. A survey study of Turkish Oncology Group

Current Problems in Cancer
2019-08 | Journal article
Contributors: Murat Araz; Mustafa Karaagac; Levent Korkmaz; Ismail Beypinar; Mukremin Uysal
Source: check_circle
Crossref

Metastatik Kolorektal Kanserli Hastaların RAS Mutasyon Durumuna Göre Klinik ve Patolojik Özellikleri

Uludağ Üniversitesi Tıp Fakültesi Dergisi
2019-08-01 | Journal article
Contributors: Mehmet SEZEN; Murat ARAZ
Source: check_circle
Crossref

Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study

Cancer Chemotherapy and Pharmacology
2019-06-08 | Journal article
Contributors: Murat Araz; Mustafa Karaagac; Levent Korkmaz; Lokman Koral; Fatih Inci; Ismail Beypinar; Mukremin Uysal; Mehmet Artac
Source: check_circle
Crossref

Are preoperative serum CA15-3 levels different in breast cancer subgroups?

Current Problems in Cancer
2019-04 | Journal article
Contributors: Murat Araz; Ismail Beypinar; Sinan Kazan; Fatih Inci; Mesut Celiker; Mukremin Uysal
Source: check_circle
Crossref

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

2019-01 | Journal article
Part of ISSN: 0344-5704
Part of ISSN: 1432-0843
Source: Self-asserted source
murat araz

A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).

Journal of B.U.ON. : official journal of the Balkan Union of Oncology
2019-01-01 | Journal article
Part of PMID: 30941962
Source: Self-asserted source
murat araz

Cetuximab Treatment for Head and Neck Skin Cancer in a Patient with Heart Transplantation

2018 | Journal article
Part of ISSN: 1306-7656
Part of ISSN: 2146-9032
Source: Self-asserted source
murat araz

Functional evaluation of treatment of chronic disease: Validity and reliability of the Turkish version of the Spiritual Well-Being Scale

2017-12 | Journal article
Part of ISSN: 1478-9515
Part of ISSN: 1478-9523
Source: Self-asserted source
murat araz

Oxaliplatin induced acute immune-mediated thrombocytopenia; a case report

2017-04 | Journal article
Part of ISSN: 2452-3364
Source: Self-asserted source
murat araz

Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology).

European review for medical and pharmacological sciences
2016-04-01 | Journal article
Part of PMID: 27097941
Source: Self-asserted source
murat araz

HER-2 positive primary solid neuroendocrine carcinoma of the breast: a case report and review of the literature

2015-07 | Journal article
Part of ISSN: 1340-6868
Part of ISSN: 1880-4233
Source: Self-asserted source
murat araz

Acute effect of palonosetron on electrocardiographic parameters in cancer patients: a prospective study

2012-10 | Journal article
Part of ISSN: 0941-4355
Part of ISSN: 1433-7339
Source: Self-asserted source
murat araz

Peer review (13 reviews for 3 publications/grants)

Review activity for Clinical & translational oncology. (1)
Review activity for PloS one. (2)
Review activity for World journal of surgical oncology (10)